Philips and Biocompatibles Team-up to Advance Image Guided Transarterial Embolizations in Interventional Oncology

Philips and Biocompatibles Team-up to Advance Image Guided Transarterial Embolizations in Interventional Oncology PR Newswire AMSTERDAM and FARNHAM, England, September 14, 2012 AMSTERDAM and FARNHAM, England, September 14, 2012 /PRNewswire/ -- Launch of collaboration marked with development of new treatment protocol for trans-arterial embolization in hypervascular tumors Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Biocompatibles, a BTG international group company, announced a collaboration to advance the use of image guidance to control the delivery of beads during the arterial embolization of hypervascularized tumors today at the annual CIRSE (Cardiovascular and Interventional Radiological Society of Europe) meeting. The first undertaking* of this new collaboration will be the development of a new treatment protocol for trans-arterial embolization - a process demonstrated to reduce the size or rate of growth of tumors. This is done by blocking the blood supply to a tumor (embolization) using an embolic material (in this case, beads). The aim of this protocol is to standardize and optimize the current approach to treatment delivery, thereby ensuring the best possible patient outcome. The trend towards such minimally invasive treatments continues to grow in interventional oncology.